|
|
You are searching for "CFAMM00432384" in compound. Total 1 results found.
Click on CFAM IDs and names to search or view in CFAM, click on external IDs to view the entity in its source database.
CFAM Mol ID | CFAMM00432384 |
Family | CFFBM15117 Substance-P receptor and Potassium voltage-gated channel subfamily H member 2 ligand AGN-PC-073QWU family |
Superfamily | CFSBM5437 Substance-P receptor and Potassium voltage-gated channel subfamily H member 2 Binder Superfamily 3 |
Class | CFCBM513 Class 3563 |
External ID | CHEMBL377819 |
External Source | CHEMBL |
PubChem CID |
44415942 |
Functional Category |
Bioactive |
Molecule Name |
N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[2-[4-(4-fluorophenyl)piperidin-1-yl]ethyl]-3-hydroxybutanamide |
IUPAC Name |
N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[2-[4-(4-fluorophenyl)piperidin-1-yl]ethyl]-3-hydroxybutanamide |
Synonyms |
AGN-PC-0764V6;CHEBI:457859;N-[[3,5-bis(trifluoromethyl)phenyl]methyl]-2-[2-[4-(4-fluorophenyl)piperidin-1-yl]ethyl]-3-hydroxybutanamide |
InChi |
InChI=1S/C26H29F7N2O2/c1-16(36)23(8-11-35-9-6-19(7-10-35)18-2-4-22(27)5-3-18)24(37)34-15-17-12-20(25(28,29)30)14-21(13-17)26(31,32)33/h2-5,12-14,16,19,23,36H,6-11,15H2,1H3,(H,34,37) |
InChiKey |
GAFLHZZCALHMLM-UHFFFAOYSA-N |
Formula | C26H29F7N2O2 |
Molecular Weight | 534.51 |
Cross Link | CHEMBL377819 |
Structure |
|
Statistics of CFAM Database |
CFAM currently contains 490,279 molecules in 87,136 families, 34,880 superfamilies and 11,643 classes. |
How to cite our database |
C. Zhang, L. Tao, C. Qin, P. Zhang, S.Y. Chen, X. Zeng, F. Xu, Z. Chen, S.Y. Yang and Y.Z. CFam: A Chemical Families Database Based on Iterative Selection of Functional Seeds and Seed-Directed Compound Clustering.
Nucl. Acids Res. 43 (D1): D558-D565 (2015) (First published online: November 20, 2014).
|
Last update by |
2014.08.29
|
48689 visits since 2014 .........
Dr.
Chen Yuzong
Deputy
Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|